Menu Content/Inhalt
Final Program

Thursday, 16th January 2014

17:30  Welcome: Alessandro Mazzucco, Verona, IT Giuseppe Faggian, Verona, IT

17:45-19:45 Hisanori Suzuki Symposium I : “Cellular preservation”

Chair: A. Mazzucco (I), L. Gottin (I) 

Myocyte: Zsoltan Papp, Debreceen, HU

Endothelium: Stefan Chlopizki, Krakow, PL

Neurons: Katharina Schmitt, Berlin, DE

Cardiovascular and cellular responses to hypothermia, hypoxia and hypercapnia. G. Strapazzon, I

20:00 Welcome cocktail and dinner   

Friday, 17th January 2014

08:00-10:00 Symposium II: “Myocardial preservation”

Chair: S. Hallström (A), G. Strapazzon (I) 

“New aspects on protection of the old heart” Bruno K. Podesser, St. Pölten, AT

"Role of inflammation in myocardial preservation", J. Wojta, Vienna, AT

“Polarized arrest- an alternative to K+-induced arrest” David Chambers, London, GB 

“New drugs in the pipeline to protect the heart” Gabor Szabo, Heidelberg, DE

10:00-10:30 Coffee break

10:30-11:30 Symposion III: “MiniOral” to all different topics Slected Abstracts

Chair: S. Hallström (A), BH. Walpoth (CH) 

An isolated large animal heart platform for cardiac device development and research. M. Granegger, Vienna, AT

Local epicardial erythropoietin-plus-fibrin patch therapy for beneficial healing after myocardial infarction. C. Klopsch, Vienna, AT

Heart failure with preserved ejection fraction: Ca2+-mediated cardiomyocyte contractile dysfunction in a rat model with stable diastolic heart failure and renal impairment. U. Primessnig, Graz, AT

Myofilament carbonylation modulates human cardiomyocyte contractility. A. Balogh, Debrecen, Hungary

Inflammatory response in cardiac grafts after antithymocyte globulin preconditioning in the brain-dead donor. J. Kremer, Vienna, AT

Influence of brain death on left ventricular pressure-volume relationship in a rat model of potential heart donor and its impact on post- transplant graft function. S. Li, Heidelberg, Germany

Neuroprotective effects of pharmacologically induced hypothermia with δ-opioid receptor agonist DADLE and cannabinoid receptor agonist WIN55,212-2 during extracorporeal life support for cardiac arrest. G. Tong, Berlin, Germany

S-nitroso human serum albumin versus inhaled nitric oxide for the treatment of pulmonary hypertension in a chronic right ventricle volume overload model. D. Linardi, Verona, IT

Tenascin-C promotes ventricular hypertrophy and fibrosis during pressure overload in the mouse heart. M. Kreibich, Vienna, AT

PlGF-MMP9 engineered cardiomyocyte-derived iPS cells supported by PEG-fibrinogen hydrogel possess an enhanced capacity to repair the damaged myocardium. C. Bearzi, Milan, IT 

14:00-16:00 Symposium IV: Poster Session and Wetlabs 

Chair: Z. Papp (HU), S. Chlopizki (PL) 

Hemodynamic energy of blood flow, endothelial effects and internal organs perfusion quality during short-term pulsatile and non-pulsatile circulatory support. M. Dodonov, Verona, IT

Will the myosin activator omecamtive mecarbil provide a potent therapeutic approach for systolic heart failure?. L. Nagy, Debrecen, HU

Investigating the vasodilating potency of two COS donators in an isolated mouse heart model. P. Haller, Vienna, AT

The expression of TNC in the murine geriatric heart after myocardial infarction. F. Nagel, Vienna, AT

Expression of specific isoforms of L-type calcium channel (LTCC) β-subunits in human atrial cardiomyocytes impacts on calcium channels activity in atrial fibrillation. M. Balycheva, Verona, IT

Impact of donor organ quality on postoperative outcome in high urgency recipients—experience of an eurotransplant center. B. Schmack, Heidelberg, Germany

N-methyl D-aspartate receptor in human heart function. D. Kosenkov, Verona, IT

Mild therapeutic hypothermia after hypoxia is neuroprotective possibly via upregulation of cold shock protein RBM3. G. Tong, Berlin, Germany

Pharmacologically induced hypothermia with cannabinoid receptor agonist WIN55,212-2 vs mild therapeutic hypothermia in a rat model of cardiac arrest with extracorporeal life support. E. Milani, Verona, IT

Effects of polarizing microplegia vs standard high-potassium depolarizing microplegia on intracellular metabolism, pro-survival kinases, and apoptosis in humans. K. Gandhi, Verona, IT

Generation of iPSC-based cardiac model systems for investigating mechanisms of dilated cardiomyopathy due to nuclear lamina defects. E. Di Pasquale, Rome, IT  

17:00-18:00 Symposium V: “Perservation of organs functions”

Chair: G. Szabo (DE), K. Schmitt (DE) 

“MicroRNA in cardiovascular diseases” Gianluigi Condorelli, Milan, IT

Intraoperative options for acutely failing hearts, A. Rajek, Vienna, AT 

18:00-18:30 Coffee break

18:30-19:15 Keynote Lecture II: “30 years of experience with the surgical therapy of end-stage heart failure” Andreas Zuckermann, Vienna, AT

Chair: G. Faggian (I), BK. Podesser (A) 

20:00 Social Dinner

Saturday, 18th January 2014

09:00-10:00 Symposium VI: “Regenerative medicine for CVD”

Chair: G. Condorelli (I), BH. Walpoth (CH) 

“Patient-specific induced pluripotent stem cells for heart regeneration” Kaomei Guan, Gottingen, DE

“Development of new techniques in cardiac regeneration” Gustav Steinhoff, Rostock, DE

10:00-10:30 Coffee break

10:30-11:30 Symposium VII: “Organ replacement”

Chair: A. Zuckermann (A), G. Steinhoff (DE) 

“Bridge-to-bridge, bridge-to-transplant or Destination therapy ?” Giuseppe Faggian, Verona, IT

“Future of vascular grafts” Beat Walpoth, Geneve, CH

11:30-12:00 „Carl Apstein Award“ and closing remarks.

Last Updated ( Montag, 13 Januar 2014 )
< Prev   Next >